FONAR Corporation (FONR)
NASDAQ: FONR · Real-Time Price · USD
15.16
+0.03 (0.20%)
Jan 14, 2025, 4:00 PM EST - Market closed

FONAR Market Cap

FONAR has a market cap or net worth of $97.01 million as of January 14, 2025. Its market cap has decreased by -28.03% in one year.

Market Cap
97.01M
Enterprise Value
84.97M
1-Year Change
-28.03%
Ranking
Category
Stock Price
$15.16

Market Cap Chart

Since December 1, 1998, FONAR's market cap has decreased from $107.60M to $97.01M, a decrease of -9.84%. That is a compound annual growth rate of -0.40%.

History

DateMarket Cap% Change
Jan 13, 2025100.70M-
Dec 31, 2024100.70M-24.68%
Dec 29, 2023133.70M15.36%
Dec 30, 2022115.90M11.55%
Dec 31, 2021103.90M-12.39%
Dec 31, 2020118.60M-11.82%
Dec 31, 2019134.50M-1.39%
Dec 31, 2018136.40M-16.01%
Dec 29, 2017162.40M29.61%
Dec 30, 2016125.30M12.88%
Dec 31, 2015111.00M65.92%
Dec 31, 201466.90M-50.66%
Dec 31, 2013135.60M372.47%
Dec 31, 201228.70M163.30%
Dec 30, 201110.90M43.42%
Dec 31, 20107.60M-13.64%
Dec 31, 20098.80M91.30%
Dec 31, 20084.60M-84.19%
Dec 31, 200729.10M-20.71%
Dec 29, 200636.70M-54.91%
Dec 30, 200581.40M-53.00%
Dec 31, 2004173.20M53.41%
Dec 31, 2003112.90M25.58%
Dec 31, 200289.90M8.57%
Dec 31, 200182.80M-4.50%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 718.08B
UnitedHealth Group 498.00B
Novo Nordisk 372.55B
Johnson & Johnson 347.83B
AbbVie 312.32B
Merck & Co. 255.44B
Thermo Fisher Scientific 212.49B
AstraZeneca 204.00B
Market Cap Rankings